Recent investigations in Bengaluru and Delhi have uncovered the alarming distribution of counterfeit medications in various hospitals. These incidents expose serious vulnerabilities in the pharmaceutical supply chain, revealing diverted cancer treatments originating from government hospitals. The issue encompasses more than just manufacturing flaws; it concerns the entire journey of drugs from suppliers to patients. Employing robust technology and verification processes is essential to curtail future instances of fake-drug rackets.
Related Posts
Michael Dell: Customers go through ‘five stages of grief’ after price hikes
In a forecast that raises concerns, Dell Technologies CEO Michael Dell has warned of an escalating semiconductor shortage that could…
‘Comprehensive sex education’ coming soon to schools, govt tells Supreme Court
India will formally introduce comprehensive sex education in schools and colleges nationwide. The government has accepted a committee’s report recommending…
Seatbelt sign off, pilot tests positive for drugs: What AI flight probe found
An Air India flight faced serious challenges with multiple hydraulic failures and altitude disturbances. Following the incident, the pilot-in-command tested…